Grufity logo
Grufity logo

Latest JOHNSON & JOHNSON Stock Portfolio

$761Million | No. of Holdings #15

JOHNSON & JOHNSON Performance

2026 Q3-6.38%
YTD+33.33%
2025+51.06%

About JOHNSON & JOHNSON and 13F Hedge Fund Stock Holdings

On 2026-10-26, the fund reported it's updated stock portfolio. In the 13F Holdings report, JOHNSON & JOHNSON reported an equity portfolio of $761.7 Millions as of 30 Sep, 2026. <br><br> The top stock holdings of JOHNSON & JOHNSON are PTGX, NBTX, MGTX. The fund has invested 45.3% of it's portfolio in PROTAGONIST THERAPEUTICS INC and 23% of portfolio in NANOBIOTIX. <br><br> The fund showed a lot of confidence in some stocks as they added substantially to CEREBRAS SYSTEMS INC.
JOHNSON & JOHNSON Equity Portfolio Value
Last Reported on: 26 Oct, 2026
$761Million
  as of Oct 26, 2026

JOHNSON & JOHNSON Annual Return Estimates Vs S&P 500

Our best estimate is that JOHNSON & JOHNSON made a return of -6.38% in the last quarter. In trailing 12 months, it's portfolio return was 50.19%.
  • Performance
  • S&P 500

New Buys

No new stocks were added by JOHNSON & JOHNSON

Additions

Ticker% Inc.
cerebras systems inc140
Additions to existing portfolio by JOHNSON & JOHNSON

Reductions

None of the existing positions were reduced by JOHNSON & JOHNSON

Sold off

None of the stocks were completely sold off by JOHNSON & JOHNSON

Sector Distribution

JOHNSON & JOHNSON has about 60.4% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare60.4
Others39.6

Market Cap. Distribution

JOHNSON & JOHNSON has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • MICRO-CAP
Category%
MID-CAP45.3
UNALLOCATED39.6
SMALL-CAP13.1
MICRO-CAP2

Stocks belong to which Index?

About 60.3% of the stocks held by JOHNSON & JOHNSON either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200060.3
Others39.7
Top 5 Winners (%)%
XNCR
xencor inc
55.0 %
PTGX
protagonist therapeutics inc
14.9 %
VOR
vor biopharma inc
3.6 %
Top 5 Winners ($)$
PTGX
protagonist therapeutics inc
44.8 M
XNCR
xencor inc
6.6 M
VOR
vor biopharma inc
0.0 M
Top 5 Losers (%)%
CVRX
cvrx inc
-66.0 %
neumora therapeutics inc.
-64.9 %
LEGN
legend biotech corp
-31.1 %
rapport therapeutics inc
-19.4 %
PRCT
procept biorobotics corp
-19.3 %
Top 5 Losers ($)$
NBTX
nanobiotix
-36.8 M
MGTX
meiragtx hldgs plc
-16.7 M
rapport therapeutics inc
-14.4 M
CVRX
cvrx inc
-13.6 M
LEGN
legend biotech corp
-7.3 M

JOHNSON & JOHNSON Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of JOHNSON & JOHNSON

JOHNSON & JOHNSON has 15 stocks in it's portfolio. About 98.8% of the portfolio is in top 10 stocks. NBTX proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for JOHNSON & JOHNSON last quarter.

$761.69MTotal Value
15.00Positions
26 Oct, 2026Last Reported
Current holdings of Current Stock Holdings of JOHNSON & JOHNSON, last reported on 26 Oct, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
LEGN
Legend Biotech Corp

Legend Biotech Corp

LEGN
JOHNSON & JOHNSON's holding in Legend Biotech Corp over time
2.13%814,586
$16.20M
2.13%
unchanged 0 percentunchanged
NBTX
Nanobiotix

Nanobiotix

NBTX
JOHNSON & JOHNSON's holding in Nanobiotix over time
23.01%5,623,820
$175.24M
23.01%
unchanged 0 percentunchanged
Com
Rapport Therapeutics Inc

Rapport Therapeutics Inc

JOHNSON & JOHNSON's holding in Rapport Therapeutics Inc over time
7.87%1,784,520
$59.96M
7.87%
unchanged 0 percentunchanged
Cl A
Contineum Therapeutics Inc

Contineum Therapeutics Inc

JOHNSON & JOHNSON's holding in Contineum Therapeutics Inc over time
3.49%1,979,170
$26.56M
3.49%
unchanged 0 percentunchanged
Com Cl A
Cerebras Systems Inc

Cerebras Systems Inc

JOHNSON & JOHNSON's holding in Cerebras Systems Inc over time
3%128,649
$22.85M
3%
increased 140.08 percentadded
Com
Neumora Therapeutics Inc.

Neumora Therapeutics Inc.

JOHNSON & JOHNSON's holding in Neumora Therapeutics Inc. over time
0.14%1,849,440
$1.10M
0.14%
unchanged 0 percentunchanged